Fla. Appeals Court Blocks Mylan’s Generic Synthroid

Law360, New York (June 23, 2009, 12:00 AM EDT) -- A Florida appellate court has held that state pharmacists cannot substitute Mylan Pharmaceuticals Inc.’s generic drug for Abbott Laboratories’ brand-name thyroid treatment Synthroid, finding that federal approval of a generic copycat does not override a state law barring the substitution of certain drugs.

In a unanimous opinion, the First District Court of Appeal in Florida determined on Monday that state law bans generic versions of certain drugs, including the drug that makes up Synthroid, and it is the responsibility of the state Legislature to make any...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.